Medical News

RSS

Bayer’s new oral contraceptive receives FDA approval

Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved a new oral contraceptive, Beyaz (drospirenone / ethinyl estradiol / levomefolate calcium tablets and levomefolate calcium tablets).

28 Sep 2010

NPL, Orla receives fund to improve detection methods for TB

Two UK companies have been awarded joint funding for a research project that could see significant advances in the quest to aid detection and eradication of Tuberculosis (TB), across the world.

28 Sep 2010

Onconova Therapeutics to present Ex-RAD radioprotectant data at RRS Annual Meeting

Onconova Therapeutics, Inc. is presenting new data in five posters and an oral presentation this week summarizing several studies with the company's radioprotectant Ex-RAD- at the 56th Annual Meeting of the Radiation Research Society (RRS), September 25-29 in Maui, Hawaii.

28 Sep 2010

RPSPP for health benefits accepted into federal program

Governor Edward G. Rendell announced today that the Retired Pennsylvania State Police Program for health benefits has been accepted into a federal program to help offset the rising health care costs for retirees.

28 Sep 2010

Report: Workers' medical costs projected to jump next year by more than 12 percent

Health care bills for an average employee are slated to climb more than $486 next year, a 12.4 percent increase from this year, according to a study by Hewitt Associates.

28 Sep 2010

Southridge, Curaxis Pharmaceutical announce $25 million equity purchase agreement

Stephen Hicks, Chairman and CEO, of Southridge LLC and Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp , jointly announced a $25 million equity purchase agreement with Southridge Partners II, an institutional investor.

28 Sep 2010

Viridis BioPharma receives approval to manufacture, market NIMBUS antimicrobial technology in India

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that its proprietary NIMBUS antimicrobial technology has been approved for manufacture, marketing and sale in India. Viridis BioPharma, an India-based manufacturer and marketer of medical devices, received approval by the Food and Drug Administration of India to manufacture and market gauze wound dressings that incorporate NIMBUS antimicrobial technology.

28 Sep 2010

Study may provide new developing approaches to treat age-related osteoporosis

Aging disrupts the balance between bone formation and bone destruction, resulting in osteoporosis, which is characterized by reduced bone mass and increased risk of fracture. Recent data have suggested that this imbalance is a result of a decrease in formation of bone forming osteoblast cells from mesenchymal cells upon aging.

28 Sep 2010

Pfizer ceases SUN 1120 Phase 3 trial of SUTENT in men with CRPC

Pfizer Inc. announced today the discontinuation of the SUN 1120 Phase 3 trial evaluating SUTENT (sunitinib malate) in combination with prednisone for men with advanced castration-resistant prostate cancer that had progressed despite treatment with a docetaxel-based chemotherapy regimen. During a scheduled interim analysis, an independent Data Monitoring Committee found that the combination of sunitinib with prednisone was unlikely to improve overall survival when compared to prednisone alone.

28 Sep 2010

Oxygen Biotherapeutics to showcase DERMACYTE oxygen-rich skin care products at Spa & Resort expo

Oxygen Biotherapeutics, Inc. will showcase for the first time its DERMACYTE oxygen-rich skin care products at the Spa & Resort/Medical Aesthetics Spa Conference and Expo at the Jacob K. Javits Convention Center in New York City starting tomorrow.

28 Sep 2010

Scientists identify gene associated with common migraines

An international study led by scientists at Universit- de Montr-al and University of Oxford, has identified a gene associated with common migraines. Their findings show that a mutation in the KCNK18 gene inhibits the function of a protein called TRESK. TRESK normally plays a key role in nerve cell communication. Published today in Nature Medicine, this study may have implications for people who suffer from recurrent headaches, which include more than six million Canadians.

28 Sep 2010

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

"The best way to help the millions of hungry people in countries that receive food aid get rid of their corrupt and incompetent rulers - and to ensure that their children will never go hungry in future — is to starve them now. That will turn them into raging, unstoppable anti-government regime changers," writes Nation Media Group Executive Editor Charles Onyango-Obbo in an East African opinion piece.

28 Sep 2010

C-CCNE receives grant to improve cancer treatment using nanotechnology

The National Cancer Institute has awarded a five-year, $13.6 million grant to the University of North Carolina at Chapel Hill's Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) based at the UNC Lineberger Comprehensive Cancer Center, for research to improve the diagnosis and treatment of cancer through applying/using advances in nanotechnology.

28 Sep 2010

Study: Genetic ancestry has no influence on how African-Americans with asthma respond to medication

Genetic ancestry has no discernible influence on how African American patients with asthma respond to medication, according to a Henry Ford Hospital study.

28 Sep 2010

MDG summit: Funding the Global Fund; Arab world's 'own challenges'

BusinessDay reports that following last week's Millennium Development Goal summit at the U.N. in New York, advocates "have called on rich nations to double their pledges to the Global Fund to Fight AIDS, Tuberculosis and Malaria, saying it desperately needs more money if the world is to meet the health-related Millennium Development Goals by 2015."

28 Sep 2010

OpGen completes Series B equity financing

OpGen, Inc., a commercial phase genomics company, today announced the successful completion of a $17 million Series B equity financing.

28 Sep 2010

AASLD, TFAH report calls for action to help identify Americans living with HBV, HCV

The American Association for the Study of Liver Diseases and the Trust for America's Health issued a new report today calling for action to be taken to transform how the country deals with viral hepatitis – to help identify millions of Americans who know they are living with chronic forms of hepatitis B and C and to assure access to treatment for all who need it, to prevent even more Americans from becoming infected.

28 Sep 2010

Many adults skip vaccines because of costs

The New York Times' Patient Money column examines the importance of vaccines for adults.

28 Sep 2010

New study shows peripheral nerves regenerate themselves after injury

Unlike nerves of the spinal cord, the peripheral nerves that connect our limbs and organs to the central nervous system have an astonishing ability to regenerate themselves after injury. Now, a new report in the October 1st issue of Cell, a Cell Press publication, offers new insight into how that healing process works.

28 Sep 2010

LIMK inhibition blocks collective invasion of tumor cells: Researchers

Researchers have shown that LIM kinase, an important regulator of actin cytoskeleton dynamics, plays a key role in cancer metastasis. The study appears online on September 27 in The Journal of Cell Biology www.jcb.org.

28 Sep 2010

Medical News

Bayer’s new oral contraceptive receives FDA approval

NPL, Orla receives fund to improve detection methods for TB

Onconova Therapeutics to present Ex-RAD radioprotectant data at RRS Annual Meeting

RPSPP for health benefits accepted into federal program

Report: Workers' medical costs projected to jump next year by more than 12 percent

Southridge, Curaxis Pharmaceutical announce $25 million equity purchase agreement

Viridis BioPharma receives approval to manufacture, market NIMBUS antimicrobial technology in India

Study may provide new developing approaches to treat age-related osteoporosis

Pfizer ceases SUN 1120 Phase 3 trial of SUTENT in men with CRPC

Oxygen Biotherapeutics to showcase DERMACYTE oxygen-rich skin care products at Spa & Resort expo

Scientists identify gene associated with common migraines

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

C-CCNE receives grant to improve cancer treatment using nanotechnology

Study: Genetic ancestry has no influence on how African-Americans with asthma respond to medication

MDG summit: Funding the Global Fund; Arab world's 'own challenges'

OpGen completes Series B equity financing

AASLD, TFAH report calls for action to help identify Americans living with HBV, HCV

Many adults skip vaccines because of costs

New study shows peripheral nerves regenerate themselves after injury

LIMK inhibition blocks collective invasion of tumor cells: Researchers

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News